Literature DB >> 21397626

Eight weeks of citicoline treatment does not perturb sleep/wake cycles in cocaine-dependent adults.

Bethany K Bracken1, David M Penetar, John Rodolico, Elizabeth T Ryan, Scott E Lukas.   

Abstract

BACKGROUND: Citicoline (cytidine-5'-diphosphate) is a mononucleotide composed of ribose, cytosine, pyrophosphate, and choline, and is involved in the biosynthesis of the structural phosopholipids of cell membranes. Treatment with citicoline, improves memory in patients with dementia, and reduces damage to the brain after traumatic brain injury or stroke. Recent research has been conducted to assess whether citicoline is an effective treatment for cocaine dependence. In cocaine-dependent individuals, withdrawal from cocaine is associated with disturbed sleep, which may contribute to the high rate of relapse to cocaine use. Therefore, it is important to know the impact of citicoline on the sleep/wake cycle in these individuals in order to rate its overall efficacy.
METHOD: In this double-blind, placebo-controlled trial, the effects of citicoline treatment on the sleep/wake cycles of cocaine dependent participants were assessed. The results of the current study are reported as part of a larger study, consisting of an eight-week treatment period to assess the efficacy of longer-term treatment with citicoline at decreasing cocaine consumption in cocaine-dependent polydrug using participants.
RESULTS: In this non-abstinent, cocaine-dependent population, citicoline had no effect on any of the sleep parameters measured including sleep efficiency, sleep latency, total sleep time, number of waking episodes, time awake per episode, amount of time in bed spent moving, number of sleep episodes, time asleep per episode, and amount of time in bed spent immobile.
CONCLUSIONS: These data suggest that eight weeks of citicoline administration does not disturb sleep/wake cycles of cocaine-dependent individuals.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21397626      PMCID: PMC3081995          DOI: 10.1016/j.pbb.2011.03.003

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  34 in total

1.  Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials.

Authors:  Antoni Dávalos; José Castillo; José Alvarez-Sabín; Julio J Secades; Joan Mercadal; Sonia López; Erik Cobo; Steven Warach; David Sherman; Wayne M Clark; Rafael Lozano
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

2.  Neuroprotective effects of citicoline on brain edema and blood-brain barrier breakdown after traumatic brain injury.

Authors:  M K Başkaya; A Doğan; A M Rao; R J Dempsey
Journal:  J Neurosurg       Date:  2000-03       Impact factor: 5.115

3.  Biosynthesis of myelin lipids of cultured nervous tissues--incorporation of choline and CDP-choline into myelin phospholipids.

Authors:  N Chida; Y Shimizu
Journal:  Tohoku J Exp Med       Date:  1973-09       Impact factor: 1.848

4.  Effects of daily treatment with citicoline: a double-blind, placebo-controlled study in cocaine-dependent volunteers.

Authors:  Stephanie C Licata; David M Penetar; Caitlin Ravichandran; John Rodolico; Christopher Palmer; Jeff Berko; Thomas Geaghan; Alison Looby; Erica Peters; Elizabeth Ryan; Perry F Renshaw; Scott E Lukas
Journal:  J Addict Med       Date:  2011-03       Impact factor: 3.702

5.  Effects of short-term citicoline treatment on acute cocaine intoxication and cardiovascular effects.

Authors:  S E Lukas; E M Kouri; C Rhee; A Madrid; P F Renshaw
Journal:  Psychopharmacology (Berl)       Date:  2001-09       Impact factor: 4.530

6.  Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.

Authors:  S Warach; L C Pettigrew; J F Dashe; P Pullicino; D M Lefkowitz; L Sabounjian; K Harnett; U Schwiderski; R Gammans
Journal:  Ann Neurol       Date:  2000-11       Impact factor: 10.422

7.  The effects of cocaine on mood and sleep in cocaine-dependent males.

Authors:  C E Johanson; T Roehrs; K Schuh; L Warbasse
Journal:  Exp Clin Psychopharmacol       Date:  1999-11       Impact factor: 3.157

8.  A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients.

Authors:  W M Clark; L R Wechsler; L A Sabounjian; U E Schwiderski
Journal:  Neurology       Date:  2001-11-13       Impact factor: 9.910

9.  Dietary cytidine (5')-diphosphocholine supplementation protects against development of memory deficits in aging rats.

Authors:  Lisa A Teather; Richard J Wurtman
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-06       Impact factor: 5.067

10.  Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine.

Authors:  Brian M Ross; Anna Moszczynska; Frank J Peretti; Vernard Adams; Gregory A Schmunk; Kathryn S Kalasinsky; Lee Ang; Nikolaos Mamalias; Sylvie D Turenne; Stephen J Kish
Journal:  Drug Alcohol Depend       Date:  2002-06-01       Impact factor: 4.492

View more
  3 in total

Review 1.  Possible Benefit and Validity of Supplements for Alcohol Use Disorder.

Authors:  Seungwoo Kang; Doo-Sup Choi
Journal:  Alcohol Clin Exp Res       Date:  2019-03-14       Impact factor: 3.455

Review 2.  Citicoline in addictive disorders: a review of the literature.

Authors:  Nicholas D Wignall; E Sherwood Brown
Journal:  Am J Drug Alcohol Abuse       Date:  2014-06-20       Impact factor: 3.829

3.  Citicoline Treatment Improves Measures of Impulsivity and Task Performance in Chronic Marijuana Smokers: A Pilot BOLD fMRI Study.

Authors:  Staci A Gruber; Kelly A Sagar; Mary Kathryn Dahlgren; Atilla Gonenç; Nina A Conn; Jeffrey P Winer; David Penetar; Scott E Lukas
Journal:  Int J Neurol Neurother       Date:  2015-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.